Full Press Release Details
Opus Genetics to Participate in Upcoming Investor Conference in April.
IRD
Opus Genetics to Participate in Upcoming Investor Conference in April
Key Takeaway: Opus Genetics to Participate in Upcoming Investor Conference in April
Price reaction · baseline $0.91 (2025-04-01 close) · hit after-hours · 1 other IRD headline(s) in the window, move may be shared
day 0 close · peak
+2.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+140%
120-day peak, hindsight
Typical move
6.3%
average across 11 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
APX3330
Phase 2 · Diabetic Retinopathy